Pharma & Biotech

Biotechnology firm Moderna is navigating one of the most challenging periods in its corporate history, implementing sweeping changes to secure...

The countdown has begun for CureVac's final days as an independent publicly traded company. A special shareholder meeting scheduled for...

A curious divergence is unfolding for Valneva's stock. While the biotech firm demonstrates significant operational improvements and dramatically curtails its...

Eli Lilly has become the first pharmaceutical company globally to surpass a $1 trillion market valuation, marking an unprecedented milestone...

BioNxt Solutions has secured a significant intellectual property milestone with the formal grant of a patent from the Eurasian Patent...

Amphastar Pharmaceuticals witnessed a significant uptick in its stock performance after releasing quarterly results that substantially outpaced market projections. The...

The Danish pharmaceutical powerhouse, once celebrated for its groundbreaking weight-loss treatment Wegovy, is confronting a severe market downturn. A combination...

Shareholders of the Tübingen-based biotech firm CureVac are approaching a decisive moment. An extraordinary general meeting scheduled for Tuesday, November...

After losing nearly 60 percent of its value since reaching all-time highs, Redcare Pharmacy shares are navigating turbulent waters, closing...

Despite securing intellectual property rights that unlock access to a vast market of more than 200 million people, Bionxt Solutions...